BLFE

    COM:BIOLIFESCIENCES

    BioLife Sciences

    • Stock

    0.00

    +0.00%

    0.00

    USD last updated 01/04 01:27:02

    Last Close

    0.00

    31/03 20:00

    Market Cap

    118

    Beta: -

    Volume Today

    50

    Avg: -

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Nov '19
    Nov '20
    Nov '21
    Nov '22
    asset turnover
    5.66
    -
    cash conversion cycle
    -128.80
    -
    cash per share
    0.00
    -
    0.00
    76,663.51%
    company equity multiplier
    -0.01
    -
    -0.11
    615.83%
    days of inventory outstanding
    days of payables outstanding
    128.80
    -
    days of sales outstanding
    dividend yield
    ebit per revenue
    -3.02
    -
    ebt per ebit
    1.02
    -
    effective tax rate
    enterprise value multiple
    -47.17
    -
    fixed asset turnover
    415.43
    -
    free cash flow per share
    0.00
    -
    -0.02
    1,956,241.62%
    gross profit margin
    -2.39
    -
    interest coverage
    -25.21
    -
    inventory turnover
    long term debt to capitalization
    net income per ebt
    1
    -
    1
    0%
    net profit margin
    -3.08
    -
    operating cash flow per share
    0.00
    -
    -0.02
    1,954,118.14%
    operating cycle
    operating profit margin
    -3.02
    -
    payables turnover
    2.83
    -
    pretax profit margin
    -3.08
    -
    price fair value
    -3.15K
    -
    -84.85
    97.31%
    receivables turnover
    return on assets
    -66.71
    -
    -17.43
    73.86%
    return on capital employed
    1.80
    -
    return on equity
    0.98
    -
    1.84
    87.08%
    total debt to capitalization
    -0.38
    -

    All numbers in USD (except ratios and percentages)